← Back to Search

Reimbursement Strategies for Breast Cancer

N/A
Waitlist Available
Led By Courtney Williams, DrPH
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to identify a financial reimbursement amount that compensates for trial-incurred expenses while minimizing financial toxicity for women with breast cancer in clinical trials.

Who is the study for?
This trial is for women with breast cancer who are already part of the I-SPY TRIAL 2 at UAB Medical Oncology Clinic. It's not open to men, non-English speakers, or female patients not enrolled in I-SPY TRIAL 2.
What is being tested?
The study is testing different amounts of money given back to participants to cover costs related to being in a clinical trial. The goal is to find out what amount feels right and helps reduce financial stress from these expenses.
What are the potential side effects?
Since this trial involves financial reimbursement rather than medical treatment, there aren't any direct physical side effects. However, it will assess how receiving money affects participants' feelings about their financial burden.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of patients who receive all reimbursements and who complete follow-up surveys (overall feasibility of intervention)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Patients receiving reimbursementExperimental Treatment1 Intervention
Monthly reimbursement to offset trial-related expenses

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,342,354 Total Patients Enrolled
31 Trials studying Breast Cancer
4,411 Patients Enrolled for Breast Cancer
Courtney Williams, DrPHPrincipal InvestigatorUniversity of Alabama at Birmingham

Media Library

Patients receiving reimbursement Clinical Trial Eligibility Overview. Trial Name: NCT05871125 — N/A
Breast Cancer Research Study Groups: Patients receiving reimbursement
Breast Cancer Clinical Trial 2023: Patients receiving reimbursement Highlights & Side Effects. Trial Name: NCT05871125 — N/A
Patients receiving reimbursement 2023 Treatment Timeline for Medical Study. Trial Name: NCT05871125 — N/A
~13 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top